Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Effects of an S84E mutation of bovine growth hormone in transgenic mice.

Schenck EJ, Brooks CL.

Exp Biol Med (Maywood). 2006 Mar;231(3):296-302.

PMID:
16514176
2.
3.

Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice.

Chen XZ, Shafer AW, Yun JS, Li YS, Wagner TE, Kopchick JJ.

Mol Endocrinol. 1992 Apr;6(4):598-606.

PMID:
1584223
4.

Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice.

Yang CW, Striker LJ, Pesce C, Chen WY, Peten EP, Elliot S, Doi T, Kopchick JJ, Striker GE.

Lab Invest. 1993 Jan;68(1):62-70.

PMID:
8423678
5.

Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity.

Chen WY, Chen NY, Yun J, Wight DC, Wang XZ, Wagner TE, Kopchick JJ.

Mol Endocrinol. 1995 Mar;9(3):292-302.

PMID:
7539887
6.

Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.

Chen NY, Chen WY, Bellush L, Yang CW, Striker LJ, Striker GE, Kopchick JJ.

Endocrinology. 1995 Feb;136(2):660-7.

PMID:
7835300
7.

Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.

Chen WY, White ME, Wagner TE, Kopchick JJ.

Endocrinology. 1991 Sep;129(3):1402-8.

PMID:
1874179
8.

Age-related changes in body composition of bovine growth hormone transgenic mice.

Palmer AJ, Chung MY, List EO, Walker J, Okada S, Kopchick JJ, Berryman DE.

Endocrinology. 2009 Mar;150(3):1353-60. doi: 10.1210/en.2008-1199. Epub 2008 Oct 23.

9.

Differential in vivo activities of bovine growth hormone analogues.

Kopchick J, Chen XZ, Li Y, Steger RW, Yun JS, Wagner TE, Bartke A.

Transgenic Res. 1998 Jan;7(1):61-71.

PMID:
9556914
10.
11.

Glycine 119 of bovine growth hormone is critical for growth-promoting activity.

Chen WY, Wight DC, Mehta BV, Wagner TE, Kopchick JJ.

Mol Endocrinol. 1991 Dec;5(12):1845-52.

PMID:
1791834
12.

Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes.

Naar EM, Bartke A, Majumdar SS, Buonomo FC, Yun JS, Wagner TE.

Biol Reprod. 1991 Jul;45(1):178-87.

PMID:
1878431
13.

Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.

Chen WY, Wight DC, Wagner TE, Kopchick JJ.

Proc Natl Acad Sci U S A. 1990 Jul;87(13):5061-5.

16.

Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.

Towns R, Kostyo JL, Vogel T, Sakal E, Tchelet A, Maher R, Gertler A.

Endocrinology. 1992 Mar;130(3):1225-30.

PMID:
1537288
17.

Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene.

Yang CW, Striker LJ, Kopchick JJ, Chen WY, Pesce CM, Peten EP, Striker GE.

Kidney Int Suppl. 1993 Jan;39:S90-4. Review.

PMID:
8468934
18.

Pituitary morphology of transgenic mice expressing bovine growth hormone.

Stefaneanu L, Kovacs K, Bartke A, Mayerhofer A, Wagner TE.

Lab Invest. 1993 May;68(5):584-91.

PMID:
8388524
19.

Consequences of overexpression of growth hormone in transgenic mice on liver cytochrome P450 enzymes.

Cheriathundam E, Doi SQ, Knapp JR, Jasser MZ, Kopchick JJ, Alvares AP.

Biochem Pharmacol. 1998 May 1;55(9):1481-7.

PMID:
10076541
20.

In-vitro mutagenesis of the bovine growth hormone gene.

Kopchick JJ, McAndrew SJ, Shafer A, Blue WT, Yun JS, Wagner TE, Chen WY.

J Reprod Fertil Suppl. 1990;41:25-35.

PMID:
2213712

Supplemental Content

Support Center